Trial · NCT02647359
Participant flow20
How many started, completed or left each group, period by period.
1 to 20 of 20
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Stage 1: Double-Masked Period (48 Weeks) | STARTED | Ataluren | 26 | |
| Stage 1: Double-Masked Period (48 Weeks) | STARTED | Placebo | 13 | |
| Stage 1: Double-Masked Period (48 Weeks) | Received at Least 1 Dose of Study Drug | Ataluren | 26 | |
| Stage 1: Double-Masked Period (48 Weeks) | Received at Least 1 Dose of Study Drug | Placebo | 13 | |
| Stage 1: Double-Masked Period (48 Weeks) | COMPLETED | Ataluren | 22 | |
| Stage 1: Double-Masked Period (48 Weeks) | COMPLETED | Placebo | 12 | |
| Stage 1: Double-Masked Period (48 Weeks) | NOT COMPLETED | Ataluren | 4 | |
| Stage 1: Double-Masked Period (48 Weeks) | NOT COMPLETED | Placebo | 1 | |
| Stage 2: Open-Label Extension (96 Weeks) | STARTED | Ataluren | 22 | |
| Stage 2: Open-Label Extension (96 Weeks) | STARTED | Placebo | 11 | |
| Stage 2: Open-Label Extension (96 Weeks) | COMPLETED | Ataluren | 12 | |
| Stage 2: Open-Label Extension (96 Weeks) | COMPLETED | Placebo | 7 | |
| Stage 2: Open-Label Extension (96 Weeks) | NOT COMPLETED | Ataluren | 10 | |
| Stage 2: Open-Label Extension (96 Weeks) | NOT COMPLETED | Placebo | 4 | |
| Open-Label Sub-Study (96 Weeks) | STARTED | Ataluren | 10 | |
| Open-Label Sub-Study (96 Weeks) | STARTED | Placebo | 7 | |
| Open-Label Sub-Study (96 Weeks) | COMPLETED | Ataluren | 2 | |
| Open-Label Sub-Study (96 Weeks) | COMPLETED | Placebo | 3 | |
| Open-Label Sub-Study (96 Weeks) | NOT COMPLETED | Ataluren | 8 | |
| Open-Label Sub-Study (96 Weeks) | NOT COMPLETED | Placebo | 4 |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02647359/flow